Skip to main content
. 2006 Mar 20;78(5):804–814. doi: 10.1086/503820

Figure 2.

Figure  2

Treatment-outcome phenotypes. Subjects who completed at least 6 wk of treatment with citalopram were assigned a remission and response phenotype that was based on the QIDS-C16 score at the last treatment visit. Those who met score criteria for remission or response after 3–6 wk of treatment were grouped with probable remitters or probable responders, respectively.